{"id":"https://genegraph.clinicalgenome.org/r/731e8778-1f7d-4cde-90aa-61fa33e17adav1.0","type":"EvidenceStrengthAssertion","dc:description":"TREX1 was first reported in relation to autosomal recessive Aicardi-Goutières syndrome (AGS) in 2006 (Crow et al., PMID: 16845398). Other reports of TREX1 variants related to autosomal dominant disorders appeared in 2007 with systemic lupus erythematosus (SLE) (Kirsch et al., PMID 17660816), in 2007 with retinal vasculopathy (Richards et al., PMID 17660820), and in 2015 with chilblain lupus (Rice et al., PMID 25703219). These conditions are considered to be forms of type 1 interferonopathy, which is defined as a condition in which increased type 1 interferon signaling leads to autoimmune and neurological disorders (MONDO:0700260). These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response. Individuals with biallelic variants in TREX1 can present with a range of symptoms of variable severity and age of onset, within the context of an autoimmune disease. \nTREX1-related type 1 interferonopathy can result from biallelic or monoallelic variants in the TREX1 gene. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we identified differences in inheritance patterns that necessitate separate curation of autosomal dominant and autosomal recessive disease entities. In this curation, the autosomal recessive TREX1-related type 1 interferonopathy is treated as a distinct entity due to its specific inheritance pattern and clinical manifestations, separate from the autosomal dominant forms.\nThis curation of autosomal recessive TREX1-related type 1 interferonopathy included three missense, three frameshift, one nonsense, and one in-frame deletion variants reported in seven probands across three publications (PMIDs: 16845398, 31130681, 25138095). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by mouse models (PMID: 15254239). \nIn summary, definitive evidence supports the relationship between TREX1 and autosomal recessive TREX1-related type 1 interferonopathy, with rigorous and reproducible evidence in research and clinical diagnostic settings. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Leukodystrophy and Leukoencephalopathy GCEP on the meeting date: June 3rd, 2024 SOP Version #10.  ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/731e8778-1f7d-4cde-90aa-61fa33e17ada","GCISnapshot":"https://genegraph.clinicalgenome.org/r/568116cb-0de8-4917-9601-add0fc2a0f5b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/568116cb-0de8-4917-9601-add0fc2a0f5b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-09-26T16:06:41.266Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/568116cb-0de8-4917-9601-add0fc2a0f5b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-06-03T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/568116cb-0de8-4917-9601-add0fc2a0f5b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/568116cb-0de8-4917-9601-add0fc2a0f5b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f25df20d-1f79-43fa-b69c-36291920b470","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdd0434a-940a-47f8-951b-0f4ce144a80a","type":"Finding","dc:description":"Humans with biallelic TREX1 experience inflammation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15254239","rdfs:label":"TREX1 Null Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/568116cb-0de8-4917-9601-add0fc2a0f5b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7bf2c17-e760-4106-ac23-4197bad4e9c0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ffe7112-28d4-44c1-bc0d-00d566e1db9b","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ffe7112-28d4-44c1-bc0d-00d566e1db9b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Quantification of the exonuclease activity revealed an approximately 20-fold reduction in exonuclease activity of TREX1R97H. Real-time PCR quantification of 11 IFN alpha inducible transcripts revealed increased amounts of messenger RNA for all 11 transcripts in the proband’s PBMCs.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4ffe7112-28d4-44c1-bc0d-00d566e1db9b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25138095","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0b215ac-d288-4807-b2ff-f511eb85fd4d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033629.6(TREX1):c.290G>A (p.Arg97His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2376620"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d7bf2c17-e760-4106-ac23-4197bad4e9c0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25138095","rdfs:label":"Ellyard 2014 Case 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c0b215ac-d288-4807-b2ff-f511eb85fd4d"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001954","obo:HP_0001369","obo:HP_0025300","obo:HP_0033726"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4ffe7112-28d4-44c1-bc0d-00d566e1db9b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6c4cdd0c-e554-435c-b76f-848accf9e9ae_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65b8f7aa-30b8-4d85-9cc9-f7db5e796b05","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65b8f7aa-30b8-4d85-9cc9-f7db5e796b05_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845398","allele":{"id":"https://genegraph.clinicalgenome.org/r/c261fd5c-a16c-4587-8524-3020b8c1d384","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033629.6(TREX1):c.490C>T (p.Arg164Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340198"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/6c4cdd0c-e554-435c-b76f-848accf9e9ae","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845398","rdfs:label":"Crow 2006 - F40","allele":{"id":"https://genegraph.clinicalgenome.org/r/c261fd5c-a16c-4587-8524-3020b8c1d384"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002448","obo:HP_0430048"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/65b8f7aa-30b8-4d85-9cc9-f7db5e796b05_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/9d97e369-2ddc-4a28-89b2-fa788bd8c25f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6bd0a082-f476-40cc-8d5a-6e17cb67f9ca","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6bd0a082-f476-40cc-8d5a-6e17cb67f9ca_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cell lines of lymphoblastoid and fibroblast origin derived from this proband showed no detectable TREX1 activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6bd0a082-f476-40cc-8d5a-6e17cb67f9ca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845398","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc39d602-d474-4888-9392-47b1a24f32e4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033629.6(TREX1):c.341G>A (p.Arg114His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116673"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9d97e369-2ddc-4a28-89b2-fa788bd8c25f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845398","rdfs:label":"Crow 2006 - F39A","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc39d602-d474-4888-9392-47b1a24f32e4"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0430048","obo:HP_0002448"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/6bd0a082-f476-40cc-8d5a-6e17cb67f9ca_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/dfda79a5-f85e-4a84-b7a9-2330c33df1f7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97e8ddbc-05af-4541-8b7f-1ab885cdc916","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97e8ddbc-05af-4541-8b7f-1ab885cdc916_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cell lines of lymphoblastoid and fibroblast origin showed no detectable TREX1 activity (Crow 2006 16845398).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/97e8ddbc-05af-4541-8b7f-1ab885cdc916_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc39d602-d474-4888-9392-47b1a24f32e4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/dfda79a5-f85e-4a84-b7a9-2330c33df1f7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","rdfs:label":"Garau 2019 - P1","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc39d602-d474-4888-9392-47b1a24f32e4"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001250","obo:HP_0001285"],"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/97e8ddbc-05af-4541-8b7f-1ab885cdc916_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/0d1a906b-818d-4415-8cdd-54b9ea16cf54_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d9efb88-fafa-4319-ad9d-df331b89c4b2","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d9efb88-fafa-4319-ad9d-df331b89c4b2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":".","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/7d9efb88-fafa-4319-ad9d-df331b89c4b2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845398","allele":{"id":"https://genegraph.clinicalgenome.org/r/5fc9ee72-0031-4921-8451-460f07d6634e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033629.6(TREX1):c.58dup (p.Glu20GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345481"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/0d1a906b-818d-4415-8cdd-54b9ea16cf54","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845398","rdfs:label":"Crow 2006 - F41","allele":{"id":"https://genegraph.clinicalgenome.org/r/5fc9ee72-0031-4921-8451-460f07d6634e"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002448","obo:HP_0430048"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/7d9efb88-fafa-4319-ad9d-df331b89c4b2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/3219cd0f-ec69-4ff0-b4ae-66c0d4dfd80c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d80288b-ac43-4b2a-8f9c-56f25472f559","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d80288b-ac43-4b2a-8f9c-56f25472f559_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Never described in the literature, presented with pulmonary hypertension and sepsis, transient thrombocytopenia, atopic dermatitis and bilateral sensorineural hearing loss at birth.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6d80288b-ac43-4b2a-8f9c-56f25472f559_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc39d602-d474-4888-9392-47b1a24f32e4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3219cd0f-ec69-4ff0-b4ae-66c0d4dfd80c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","rdfs:label":"Garau 2019 - P4","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc39d602-d474-4888-9392-47b1a24f32e4"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000407","obo:HP_0002092","obo:HP_0001638","obo:HP_0001285"],"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6d80288b-ac43-4b2a-8f9c-56f25472f559_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6f05cad3-6889-4b1e-bdda-dd05093144fa_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e84da3b-6873-4458-a4d0-9dd82789ae12","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e84da3b-6873-4458-a4d0-9dd82789ae12_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The independently derived AGS fibroblast cell lines from this proband with a unique catalytic-site mutation showed no detectable TREX1 activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6e84da3b-6873-4458-a4d0-9dd82789ae12_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845398","allele":{"id":"https://genegraph.clinicalgenome.org/r/7b6c9d89-c8a9-4cbd-8cb8-c43c3e74e401","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033629.6(TREX1):c.602T>A (p.Val201Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340203"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6f05cad3-6889-4b1e-bdda-dd05093144fa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16845398","rdfs:label":"Crow 2006 - F47","allele":{"id":"https://genegraph.clinicalgenome.org/r/7b6c9d89-c8a9-4cbd-8cb8-c43c3e74e401"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0430048","obo:HP_0002448"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/6e84da3b-6873-4458-a4d0-9dd82789ae12_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/28152bd0-8457-4757-85f3-9d2ab1fa1435_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74c9f3a4-2bcb-4add-9c92-d5bf851d6cc3","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74c9f3a4-2bcb-4add-9c92-d5bf851d6cc3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":".","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/74c9f3a4-2bcb-4add-9c92-d5bf851d6cc3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","allele":{"id":"https://genegraph.clinicalgenome.org/r/be3068de-3f56-4778-a1ac-505a1034bf42","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033629.6(TREX1):c.150_151del (p.Gln51GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2376580"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/28152bd0-8457-4757-85f3-9d2ab1fa1435","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31130681","rdfs:label":"Garau 2019 - P3","allele":{"id":"https://genegraph.clinicalgenome.org/r/be3068de-3f56-4778-a1ac-505a1034bf42"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001638","obo:HP_0001285"],"secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/74c9f3a4-2bcb-4add-9c92-d5bf851d6cc3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9053,"specifiedBy":"GeneValidityCriteria10","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/0C9xtOAl1MM","type":"GeneValidityProposition","disease":"obo:MONDO_0700256","gene":"hgnc:12269","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_568116cb-0de8-4917-9601-add0fc2a0f5b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}